| Announce Date | 01/26/2026 |
| EPS Normalized Actual | $1.73 (Miss by $-0.18) |
| EPS GAAP Actual | $1.73 (Miss by $-0.18) |
| Revenue Actual | $7.687B |
| Revenue Surprise | Beat by $7687M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2030 | 17.8391 | 10.73 | 16.98945 | 18.66286 | 1 |
| Dec 2029 | 18.078 | 10.59 | 17.25725 | 18.94857 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | 5.89 | 5.89 | 8.521B | 16.96% | 8521M |
| FQ3 2025 (Jul 2025) | 2.6 | 2.6 | 8.456B | 11.97% | 8456M |
| FQ2 2025 (Apr 2025) | 0.67 | 0.67 | 7.83B | -3.16% | 7830M |
| FQ4 2024 (Dec 2024) | 1.23 | 1.23 | 7.076B | -8.88% | 7076M |
| FQ3 2024 (Sep 2024) | 1.06 | 1.06 | 7.44416B | 100% | 7444.16M |
| FQ4 2023 (Dec 2023) | 3.17 | 3.17 | 7.70453B | 100% | 7704.53M |
| FQ1 2024 (Mar 2024) | 3.46 | 3.46 | 8.13708B | -7.04% | 8137.08M |
| FQ2 2024 (Jun 2024) | 2.69 | 2.69 | 8.07717B | -17.9% | 8077.17M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2030 (Oct 2030) | 4.3676 | -- | 4.23399 | 4.47859 | 3 |
| FQ3 2030 (Jul 2030) | 5.0536 | -- | 4.89901 | 5.18202 | 3 |
| FQ2 2030 (Apr 2030) | 4.6634 | -- | 4.52074 | 4.7819 | 3 |
| FQ1 2030 (Jan 2030) | 4.0877 | -- | 3.92298 | 4.27945 | 1 |
| FQ4 2029 (Oct 2029) | 4.743 | -- | 4.55187 | 4.96549 | 1 |
| FQ3 2029 (Jul 2029) | 5.4738 | -- | 5.25322 | 5.73057 | 1 |
| FQ2 2029 (Apr 2029) | 5.2452 | -- | 5.03384 | 5.49124 | 1 |
| FQ1 2029 (Mar 2029) | 4.8618 | -- | 4.7453 | 5.04555 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2030 (Oct 2030) | 10.18B | -- | 9.94B | 10.37B | 2 |
| FQ3 2030 (Jul 2030) | 10.55B | -- | 10.31B | 10.76B | 2 |
| FQ2 2030 (Apr 2030) | 9.98B | -- | 9.75B | 10.18B | 2 |
| FQ1 2030 (Jan 2030) | 9.89B | -- | 9.58B | 10.25B | 4 |
| FQ4 2029 (Oct 2029) | 10.35B | -- | 10.03B | 10.73B | 4 |
| FQ3 2029 (Jul 2029) | 10.68B | -- | 10.35B | 11.07B | 4 |
| FQ2 2029 (Apr 2029) | 10.41B | -- | 10.09B | 10.79B | 4 |
| FQ1 2029 (Mar 2029) | 10.38B | -- | 10.19B | 10.68B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | 5.89 | 5.89 | 100% | |
| FQ3 2025 (Jul 2025) | 2.6 | 2.6 | 100% | |
| FQ2 2025 (Apr 2025) | 0.67 | 0.67 | 100% | |
| FQ4 2024 (Dec 2024) | 1.23 | 1.23 | 100% | |
| FQ3 2024 (Sep 2024) | 1.06 | 1.06 | 100% | |
| FQ4 2023 (Dec 2023) | 3.17 | 3.17 | 100% | |
| FQ1 2024 (Mar 2024) | 3.46 | 3.46 | 100% | |
| FQ2 2024 (Jun 2024) | 2.69 | 2.69 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | $0B | $8.52B | $8521M | 100% |
| FQ3 2025 (Jul 2025) | $0B | $8.46B | $8456M | 100% |
| FQ2 2025 (Apr 2025) | $0B | $7.83B | $7830M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $7.08B | $7076M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $7.44B | $7444.16M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $7.7B | $7704.53M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $8.14B | $8137.08M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $8.08B | $8077.17M | 100% |